Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- GARLAND H. Diabetic amyotrophy. Br Med J. 1955 Nov 26;2(4951):1287–1290. doi: 10.1136/bmj.2.4951.1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GARLAND H., TAVERNER D. Diabetic myelopathy. Br Med J. 1953 Jun 27;1(4825):1405–1408. doi: 10.1136/bmj.1.4825.1405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jaspan J., Maselli R., Herold K., Bartkus C. Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function. Lancet. 1983 Oct 1;2(8353):758–762. doi: 10.1016/s0140-6736(83)92296-1. [DOI] [PubMed] [Google Scholar]
- Leedman P. J., Davis S., Harrison L. C. Diabetic amyotrophy: reassessment of the clinical spectrum. Aust N Z J Med. 1988 Oct;18(6):768–773. doi: 10.1111/j.1445-5994.1988.tb00177.x. [DOI] [PubMed] [Google Scholar]
- Seddon P. C., Smith C. S. Adolescent diabetic amyotrophy. Acta Paediatr Scand. 1988 Nov;77(6):937–939. doi: 10.1111/j.1651-2227.1988.tb10788.x. [DOI] [PubMed] [Google Scholar]
- Ward J. D. Diabetic neuropathy. Br Med Bull. 1989 Jan;45(1):111–126. doi: 10.1093/oxfordjournals.bmb.a072307. [DOI] [PubMed] [Google Scholar]
